Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02928575
Title Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bassam Abdulkarim
Indications

glioblastoma

Therapies

Sunitinib + Temozolomide

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.